Donepezil and Cognitive Remediation Therapy to Augment Treatment of Alcohol use Disorder Related Mild Cognitive Impairment (AUD-MCI): An Open Label Pilot Study with Historical Controls

神经认知 多奈哌齐 酒精使用障碍 精神科 痴呆 心理学 医学 临床全球印象 认知 临床心理学 内科学 安慰剂 酒 疾病 生物化学 化学 病理 替代医学
作者
Morris D. Bell,Brian Pittman,Ismene L. Petrakis,Gihyun Yoon
出处
期刊:Substance Abuse [SAGE Publishing]
卷期号:42 (4): 412-416 被引量:4
标识
DOI:10.1080/08897077.2020.1844847
摘要

Background Pharmacological and psychosocial interventions have only modest efficacy for Alcohol Use Disorder (AUD), and continued alcohol use has brain effects on neurocognition, which place heavy drinkers at increased risk of early onset dementia. The most common neurocognitive deficits are in the domains of executive function and memory, and these deficits may impact AUD treatment outcomes. AUD related Mild Cognitive Impairment (AUD-MCI) is a diagnosis in DSM-V and ICD-10. Donepezil, a cholinesterase inhibitor, is currently FDA approved for treatment of dementia, and recent preclinical research suggests anticholinesterase agents may treat alcoholism. Another approach to cognitive recovery is Cognitive Remediation Therapy (CRT). Recent research supports CRT efficacy in schizophrenia and related disorders, and some research suggests that CRT could improve neurocognition in substance abuse disorders (SUDs). This is the first report of an open-label clinical trial that combined donepezil with CRT to improve neurocognitive and clinical outcomes in the early phase of AUD recovery. Methods Eleven older male US Veterans with AUD-MCI as determined by Level II neurocognitive criteria and who had recently relapsed participated in an open-label trial of 13 weeks of donepezil combined with CRT. They were compared with matched historical control samples on neurocognitive and clinical outcomes. Results Participants had excellent adherence to donepezil and CRT. Neurocognitive improvements were highly significant on a composite score of learning and memory and executive function measures ( p < .0001) and was significantly better than historical matched controls ( p < .001). On a Clinical Global Impression scale, 90.9% of participants had a good clinical recovery compared with 59.5% of historical matched controls ( p <.052). Conclusions AUD-MCI has not received much research attention but is of considerable public health importance. Findings in this open-label trial of donepezil + CRT should encourage further investigation into the clinical benefit of this combined treatment for AUD-MCI.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
小羊发布了新的文献求助10
刚刚
刚刚
JDK发布了新的文献求助30
刚刚
今后的应助被新楚采纳,获得10
1秒前
1秒前
molihuakai的应助被gsgg采纳,获得10
1秒前
俏皮的沉鱼完成签到,获得积分20
1秒前
1秒前
1秒前
王一发布了新的文献求助10
1秒前
完美世界的应助被King强采纳,获得20
2秒前
2秒前
qolke完成签到,获得积分10
2秒前
HAi完成签到,获得积分10
2秒前
mike发布了新的文献求助10
2秒前
元谷雪的应助被drizzle采纳,获得10
3秒前
Camellia完成签到,获得积分10
5秒前
syh发布了新的文献求助10
5秒前
这样说话完成签到,获得积分10
5秒前
kk完成签到,获得积分10
6秒前
野木生花发布了新的文献求助30
7秒前
7秒前
清风慕竹发布了新的文献求助10
7秒前
7秒前
8秒前
9秒前
linglingling完成签到,获得积分10
9秒前
9秒前
华仔的应助被知有采纳,获得10
10秒前
10秒前
11秒前
11秒前
11秒前
walawala的应助被文艺的小刺猬采纳,获得10
11秒前
11秒前
11秒前
11秒前
11秒前
walawala的应助被文艺的小刺猬采纳,获得10
11秒前
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
Resource Recovery Handbook 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8175707
求助须知:如何正确求助?哪些是违规求助? 9567353
关于积分的说明 21792214
捐赠科研通 7770334
什么是DOI,文献DOI怎么找? 3431908
关于科研通互助平台的介绍 2556260
邀请新用户注册赠送积分活动 2477417